BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12228133)

  • 21. A novel method for colposcopic shunting in HPV-positive women: Quantitative detection of HPV E7 oncoprotein.
    Wang X; Zhang H; Chen L; Xu J; Qu P
    Heliyon; 2024 Feb; 10(4):e25238. PubMed ID: 38420415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variations in Genes Encoding Human Papillomavirus Binding Receptors and Susceptibility to Cervical Precancer.
    Mukherjee A; Ye Y; Wiener HW; Kuniholm MH; Minkoff H; Michel K; Palefsky J; D'Souza G; Rahangdale L; Butler KR; Kempf MC; Sudenga SL; Aouizerat BE; Ojesina AI; Shrestha S
    Cancer Epidemiol Biomarkers Prev; 2023 Sep; 32(9):1190-1197. PubMed ID: 37410084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Canadian Guideline on the Management of a Positive Human Papillomavirus Test and Guidance for Specific Populations.
    Zigras T; Mayrand MH; Bouchard C; Salvador S; Eiriksson L; Almadin C; Kean S; Dean E; Malhotra U; Todd N; Fontaine D; Bentley J
    Curr Oncol; 2023 Jun; 30(6):5652-5679. PubMed ID: 37366908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Hybrid Capture 2 Results in Correlation with the Pap Test, Sexual Behavior, and Characteristics of Romanian Women.
    Voidăzan TS; Uzun CC; Kovacs Z; Rosznayai FF; Turdean SG; Budianu MA
    Int J Environ Res Public Health; 2023 Feb; 20(5):. PubMed ID: 36900850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical implementation of a cervical cancer screening program via co-testing at a university hospital.
    Denninghoff V; von Petery F; Fresno C; Galarza M; Torres F; Avagnina A; Fishkel V; Krupitzki H; Fiorillo A; Monge F
    PLoS One; 2022; 17(12):e0278476. PubMed ID: 36454784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phylogenomic Analysis of Human Papillomavirus Type 31 and Cervical Carcinogenesis: A Study of 2093 Viral Genomes.
    Pinheiro M; Harari A; Schiffman M; Clifford GM; Chen Z; Yeager M; Cullen M; Boland JF; Raine-Bennett T; Steinberg M; Bass S; Xiao Y; Tenet V; Yu K; Zhu B; Burdett L; Turan S; Lorey T; Castle PE; Wentzensen N; Burk RD; Mirabello L
    Viruses; 2021 Sep; 13(10):. PubMed ID: 34696378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human Papillomavirus and Squamous Cell Carcinoma of Unknown Primary in the Head and Neck Region: A Comprehensive Review on Clinical Implications.
    Larsen MHH; Channir HI; von Buchwald C
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of influencing factors of viral load in patients with high-risk human papillomavirus.
    Lu X; Wang T; Zhang Y; Liu Y
    Virol J; 2021 Jan; 18(1):6. PubMed ID: 33407635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaginal microbiota diversity and paucity of Lactobacillus species are associated with persistent hrHPV infection in HIV negative but not in HIV positive women.
    Dareng EO; Ma B; Adebamowo SN; Famooto A; Ravel J; Pharoah PP; Adebamowo CA
    Sci Rep; 2020 Nov; 10(1):19095. PubMed ID: 33154533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs.
    Demarco M; Hyun N; Carter-Pokras O; Raine-Bennett TR; Cheung L; Chen X; Hammer A; Campos N; Kinney W; Gage JC; Befano B; Perkins RB; He X; Dallal C; Chen J; Poitras N; Mayrand MH; Coutlee F; Burk RD; Lorey T; Castle PE; Wentzensen N; Schiffman M
    EClinicalMedicine; 2020 May; 22():100293. PubMed ID: 32510043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Study of Partial Human Papillomavirus Genotyping in Support of the 2019 ASCCP Risk-Based Management Consensus Guidelines.
    Demarco M; Egemen D; Raine-Bennett TR; Cheung LC; Befano B; Poitras NE; Lorey TS; Chen X; Gage JC; Castle PE; Wentzensen N; Perkins RB; Guido RS; Schiffman M
    J Low Genit Tract Dis; 2020 Apr; 24(2):144-147. PubMed ID: 32243309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human papillomavirus Posttreatment Clearance Time in Cervical Intraepithelial Neoplasia and Invasive Cervical Cancer.
    Abudurexiti G; Tuerxun G; Abulizi G; Mijiti P; Aierken K; Maimaiti A; Li H
    J Low Genit Tract Dis; 2020 Jan; 24(1):34-37. PubMed ID: 31725049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HPV infection screening using surface plasmon resonance in women from Kunming (Southwest China).
    Liu Y; Quan Y; Xu C; Huang Y; Li D; Qing Q; Sun C; Zhou H
    Bosn J Basic Med Sci; 2020 Feb; 20(1):125-130. PubMed ID: 31509732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlates of cervical cancer screening uptake among female under graduate students of Aksum University, College of Health Sciences, Tigray, Ethiopia.
    Gebregziabher D; Berhanie E; Birhanu T; Tesfamariam K
    BMC Res Notes; 2019 Aug; 12(1):520. PubMed ID: 31426848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of precancerous cervical lesions in women attending Mezam Polyclinic Bamenda, Cameroon.
    Nkfusai NC; Mubah TM; Yankam BM; Tambe TA; Cumber SN
    Pan Afr Med J; 2019; 32():174. PubMed ID: 31303943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Residual or Recurrent Precancerous Lesions After Treatment of Cervical Lesions in Human Immunodeficiency Virus-infected Women: A Systematic Review and Meta-analysis of Treatment Failure.
    Debeaudrap P; Sobngwi J; Tebeu PM; Clifford GM
    Clin Infect Dis; 2019 Oct; 69(9):1555-1565. PubMed ID: 30602038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and validation of a method for human papillomavirus genotyping based on molecular beacon probes.
    Lyu J; Yu Y; Pan C; Zhou J; Ren X
    PLoS One; 2018; 13(11):e0207930. PubMed ID: 30496224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of age on histologic outcome of cervical intraepithelial neoplasia during observational management: results from large cohort, systematic review, meta-analysis.
    Bekos C; Schwameis R; Heinze G; Gärner M; Grimm C; Joura E; Horvat R; Polterauer S; Polterauer M
    Sci Rep; 2018 Apr; 8(1):6383. PubMed ID: 29686397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer.
    Komdeur FL; Prins TM; van de Wall S; Plat A; Wisman GBA; Hollema H; Daemen T; Church DN; de Bruyn M; Nijman HW
    Oncoimmunology; 2017; 6(9):e1338230. PubMed ID: 28932636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Folate Receptor-targeted Bioflavonoid Genistein-loaded Chitosan Nanoparticles for Enhanced Anticancer Effect in Cervical Cancers.
    Cai L; Yu R; Hao X; Ding X
    Nanoscale Res Lett; 2017 Aug; 12(1):509. PubMed ID: 28853026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.